715 related articles for article (PubMed ID: 17941081)
1. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis.
Gao XM; Wong G; Wang B; Kiriazis H; Moore XL; Su YD; Dart A; Du XJ
J Hypertens; 2006 Aug; 24(8):1663-70. PubMed ID: 16877971
[TBL] [Abstract][Full Text] [Related]
3. Raptor-rictor axis in TGFbeta-induced protein synthesis.
Das F; Ghosh-Choudhury N; Mahimainathan L; Venkatesan B; Feliers D; Riley DJ; Kasinath BS; Choudhury GG
Cell Signal; 2008 Feb; 20(2):409-23. PubMed ID: 18068336
[TBL] [Abstract][Full Text] [Related]
4. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
Fang CX; Yang X; Sreejayan N; Ren J
Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload.
McMullen JR; Sherwood MC; Tarnavski O; Zhang L; Dorfman AL; Shioi T; Izumo S
Circulation; 2004 Jun; 109(24):3050-5. PubMed ID: 15184287
[TBL] [Abstract][Full Text] [Related]
6. Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability.
Beugnet A; Tee AR; Taylor PM; Proud CG
Biochem J; 2003 Jun; 372(Pt 2):555-66. PubMed ID: 12611592
[TBL] [Abstract][Full Text] [Related]
7. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.
Rommel C; Bodine SC; Clarke BA; Rossman R; Nunez L; Stitt TN; Yancopoulos GD; Glass DJ
Nat Cell Biol; 2001 Nov; 3(11):1009-13. PubMed ID: 11715022
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
[TBL] [Abstract][Full Text] [Related]
9. Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy.
Chen JK; Chen J; Neilson EG; Harris RC
J Am Soc Nephrol; 2005 May; 16(5):1384-91. PubMed ID: 15788477
[TBL] [Abstract][Full Text] [Related]
10. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
Bibollet-Bahena O; Almazan G
J Neurochem; 2009 Jun; 109(5):1440-51. PubMed ID: 19453943
[TBL] [Abstract][Full Text] [Related]
11. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.
Follo MY; Mongiorgi S; Bosi C; Cappellini A; Finelli C; Chiarini F; Papa V; Libra M; Martinelli G; Cocco L; Martelli AM
Cancer Res; 2007 May; 67(9):4287-94. PubMed ID: 17483341
[TBL] [Abstract][Full Text] [Related]
12. Translation of the radioresistance kinase TLK1B is induced by gamma-irradiation through activation of mTOR and phosphorylation of 4E-BP1.
Sunavala-Dossabhoy G; Fowler M; De Benedetti A
BMC Mol Biol; 2004 Apr; 5():1. PubMed ID: 15070431
[TBL] [Abstract][Full Text] [Related]
13. Testosterone induces cardiomyocyte hypertrophy through mammalian target of rapamycin complex 1 pathway.
Altamirano F; Oyarce C; Silva P; Toyos M; Wilson C; Lavandero S; Uhlén P; Estrada M
J Endocrinol; 2009 Aug; 202(2):299-307. PubMed ID: 19474060
[TBL] [Abstract][Full Text] [Related]
14. Rheb activation of mTOR and S6K1 signaling.
Hanrahan J; Blenis J
Methods Enzymol; 2006; 407():542-55. PubMed ID: 16757352
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy.
Kuzman JA; O'Connell TD; Gerdes AM
Endocrinology; 2007 Jul; 148(7):3477-84. PubMed ID: 17395699
[TBL] [Abstract][Full Text] [Related]
16. Chronic paraplegia-induced muscle atrophy downregulates the mTOR/S6K1 signaling pathway.
Dreyer HC; Glynn EL; Lujan HL; Fry CS; DiCarlo SE; Rasmussen BB
J Appl Physiol (1985); 2008 Jan; 104(1):27-33. PubMed ID: 17885021
[TBL] [Abstract][Full Text] [Related]
17. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo.
Bodine SC; Stitt TN; Gonzalez M; Kline WO; Stover GL; Bauerlein R; Zlotchenko E; Scrimgeour A; Lawrence JC; Glass DJ; Yancopoulos GD
Nat Cell Biol; 2001 Nov; 3(11):1014-9. PubMed ID: 11715023
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma.
Wan X; Mendoza A; Khanna C; Helman LJ
Cancer Res; 2005 Mar; 65(6):2406-11. PubMed ID: 15781656
[TBL] [Abstract][Full Text] [Related]
19. Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways.
Clemente CF; Xavier-Neto J; Dalla Costa AP; Consonni SR; Antunes JE; Rocco SA; Pereira MB; Judice CC; Strauss B; Joazeiro PP; Matos-Souza JR; Franchini KG
J Mol Cell Cardiol; 2012 Feb; 52(2):493-501. PubMed ID: 22056317
[TBL] [Abstract][Full Text] [Related]
20. Maximal lengthening contractions increase p70 S6 kinase phosphorylation in human skeletal muscle in the absence of nutritional supply.
Eliasson J; Elfegoun T; Nilsson J; Köhnke R; Ekblom B; Blomstrand E
Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1197-205. PubMed ID: 16835402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]